Oyster Point Pharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Oyster Point Pharma, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 2.56 million shares as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2022-11-10
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.56M shares.
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.29M shares.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.11M shares.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.86M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2022-09-30 | 2.56M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 2.29M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 2.11M shares 10-Q · filed 2022-05-05 |
| 2021-12-31 | 1.86M shares 10-K · filed 2022-02-24 |
| 2021-09-30 | 2.06M shares 10-Q · filed 2021-11-04 |
| 2021-06-30 | 1.95M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 1.79M shares 10-Q · filed 2021-05-06 |
| 2020-12-31 | 1.56M shares 10-K · filed 2021-02-18 |
| 2020-09-30 | 1.42M shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 1.29M shares 10-Q · filed 2020-08-05 |
| 2020-03-31 | 1.23B shares 10-Q · filed 2020-05-11 |
| 2019-12-31 | 1.11B shares 10-K · filed 2020-02-27 |